Thurs. June 13, 2024

SoWa Power Station

550 Harrison Ave

Boston, MA 02118

11:30 AM - 5:30 PM ET

Lunch & Cocktail Hour Included


Join us at the Boston Life Sciences IPO Summit hosted at the SoWa Power Station! Executives and leaders from top life science companies and the IPO ecosystem will converge making it an unmissable occasion. This year promises an impressive audience with the increasing optimism for 2024 and 2025 IPO markets.

Expert speakers include life science executives, investment bankers and IPO specialists from Connor Group, DFIN, Latham & Watkins, Nasdaq and NetSuite. Don't miss out on the opportunity to be part of this dynamic summit!

We’re excited to announce some of our speakers will include:
• Goldman Sachs | Ryan Fisk, Managing Director, Healthcare Investment Banking
• Fractyl Health | Lisa Davidson, CFO
• Neumora | Michael Milligan, SVP Finance & Principal Accounting Officer
• Structure Therapeutics, Dice Molecules | Sharon Tetlow, Board Member
• EY | Christopher Pereira, Audit Partner
• Life Science Experts with hundreds of IPO Transactions from Connor Group, DFIN, Latham, Nasdaq and NetSuite.
• Special guest to include former NBA hall of fame player
• More speaker announcements to come!

Complete the form to register.


  • Registration Opens

  • Networking Lunch

  • Opening Remarks

    Jim Neesen, Partner | Connor Group

  • Capital Markets Panel

    Jordan Saxe, Senior Managing Director - Americas | Nasdaq

    Ryan Fisk, Managing Director | Goldman Sachs

  • CFO/CAO Panel on IPO Readiness

    Moderator: Matt Lepley, Partner | Connor Group

    Lisa Davidson, CFO | Fractyl Health

    Michael Milligan, CAO | Neumora Therapeutics

  • Break

  • Executive Compensation Panel

    Josh Friedman, Partner | Latham & Watkins

    Dana Etra, Managing Director | FW Cook

  • Technology Stack for Life Sciences

    Moderator: Meaghan Miller, Vice President, Global Capital Markets | DFIN

    Anand Dixit, Consulting Solutions Sr. Director | NetSuite

    Ajim Tamboli, CFO | Arbor Biotechnologies

  • Public Company Readiness (Legal, Audit, Board)

    Moderator: Elisabeth Martin, Partner | Latham & Watkins

    Christopher Pereira, Partner | EY

    Sharon Tetlow, Board Member | Structure Therapeutics, Dice Molecules

  • Closing Remarks

  • Networking Reception

Event Hosts

This year's event is presented by: